About Us | Entos

About us

Reimagining drug discovery to better serve patients

Entos is disrupting drug discovery with a cutting-edge platform that integrates novel physics-informed AI design with high-throughput experimentation. Headquartered in La Jolla, CA, the Entos team includes Nobel laureates, renowned scientists, and industry leaders in machine learning, laboratory automation, and biotechnology. Entos is advancing a pipeline of oncology therapeutics, addressing urgent patient need at the pace of program-launch-to-clinic in two years.

Join our team

Our investment partners

Company Board

Tom Miller

CEO at Entos

Fred Manby

CTO at Entos

Jishnu Bhattacharjee

Managing Director at Nexus Venture Partners

Jacob Vogelstein

Co-founder and Managing Partner at Catalio Capital Management LP

Aaron Weiner

Managing Director and Head of Healthcare at Coatue

Leadership

Lorem ipsum dolor sit amet, consectetur adipiscing elit. At mattis rutrum sed tempor ullamcorper eget ut morbi quis.

Mary Anderson

SVP, Business Development

Laurent Gomez

VP, Discovery chemistry

Jeanne Grover

Director, Finance and Operations

John Huang

VP, Biology

Fred Manby

CTO

Tom Miller

CEO

José Quiroz

Executive Director, HTE Operations

Tabbert Teng

VP, Finance

Matt Welborn

Director, Machine Learning

Chao Zhang

CSO

Hui Zhang

VP, Analytical Technologies

Scientific Advisory Board

Lorem ipsum dolor sit amet, consectetur adipiscing elit. At mattis rutrum sed tempor ullamcorper eget ut morbi quis.

Frances Arnold

Nobel Prize in Chemistry. Linus Pauling Professor at Caltech. Member of President's Science and Tech Advisory Board and Alphabet Board of Directors.

Derek Lowe

Director in Chemical Biology Therapeutics at Novartis, and author of In the Pipeline at Science Magazine.

Nick Saccomano

Former CSO/SVP at Pfizer Boulder and former CSO, Array Biopharma.

Connor Coley

Assistant Professor of Chemical Engineering at Massachusetts Institute of Technology.

Jack Taunton

Professor of Cellular Molecular Pharmacology at UCSF, co-founder of Cedilla, Principia Biopharma, GBT, Kezar.

Ken Brameld

Senior Advisor for Samsara Biocapital, and former SVP Head of Research, Principia Biopharma.

Scientific advisory board

We are actively supported through our distinguished network of scientific and business advisors.

Frances Arnold

Nobel Prize in Chemistry. Linus Pauling Professor at Caltech. Member of President's Science and Tech Advisory Board and Alphabet Board of Directors.

Connor Coley

Assistant Professor of Chemical Engineering at Massachusetts Institute of Technology.

Derek Lowe

Director in Chemical Biology Therapeutics at Novartis, and author of In the Pipeline at Science Magazine.

Jack Taunton

Professor of Cellular Molecular Pharmacology at UCSF, co-founder of Cedilla, Principia Biopharma, GBT, Kezar.

Ken Brameld

Senior Advisor for Samsara Biocapital, and former SVP Head of Research, Principia Biopharma.

Nick Saccomano

Former CSO/SVP at Pfizer Boulder and former CSO, Array Biopharma.

Scientific collaborators

Lorem ipsum dolor sit amet consectetur adipiscing elit ultrices blandit duis lorem elementum lacinia

Anima Anandkumar

Bren Professor of Computing at Caltech.

Mission

Collaborative discovery

We're building a diverse team of scientists and technologists to transform the discovery of small molecule therapeutics for patients with cancer.

We liberate our people to innovate, collaborate, and problem-solve. We emphasize productive communication networks, and we believe that every team member can and should play a role in helping others perform at their best.

Our core values are:

Innovation through collaboration and respecting different view-points
Continuously supporting each other to do our best work
Giving each person the autonomy to tackle the biggest challenges

Join our team

Headquartered in San Diego

Our headquarters and state-of-the-art laboratory facilities are located in La Jolla on the UCSD Science Research Park